NCT01502449

Brief Summary

This study will evaluate a telephone-delivered cognitive-behavioral psychotherapy intervention designed for primary care treatment of combat-exposed service members with PTSD. The investigators will assess Posttraumatic Stress Disorder (PTSD) symptoms, mental health-related and occupational functioning, and symptoms of depression, anxiety, and somatization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2011

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 30, 2011

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 12, 2012

Status Verified

January 1, 2012

Enrollment Period

2 years

First QC Date

December 12, 2011

Last Update Submit

January 11, 2012

Conditions

Keywords

telemedicine, telephonic, PTSD

Outcome Measures

Primary Outcomes (1)

  • Posttraumatic Stress Disorder Checklist - Civilian Version (PCL)

    Symptoms of PTSD will be assessed using the PTSD Checklist-Civilian Version. The PCL is a self-report measure developed for measuring PTSD symptom severity and for estimating PTSD caseness when administration of a structured clinical interview is not feasible. Respondents rate PCL items on a 5-point scale ("not at all" through "extremely") to indicate the degree to which they have been bothered by each of 17 PTSD symptoms during the past month. Possible PCL scores range from 17 to 85.

    Baseline, 12 weeks, 18 weeks, and 24 weeks

Secondary Outcomes (7)

  • Medical Outcomes Survey Short-Form-12 (SF-12)

    Baseline, 12 weeks, 18 weeks, and 24 weeks

  • World Health Organization Health & Work Performance Questionnaire (HPQ)

    Baseline, 12 weeks, 18 weeks, and 24 weeks

  • Patient Health Questionnaire (PHQ)

    Baseline, 12 weeks, 18 weeks, and 24 weeks

  • Generalized Anxiety Symptom Severity (GAD-7)

    Baseline

  • Sheehan Disability Scale (SDS)

    baseline, 12 week, 18 week and 24 week

  • +2 more secondary outcomes

Study Arms (2)

DESTRESS-T

EXPERIMENTAL

Usual primary care PTSD treatment, plus a telephone care management program over 8 weeks that includes: four outreach calls, feedback to the treating primary care provider, and care coordination

Behavioral: DESTRESS-T

Optimized Usual Care (OUC)

ACTIVE COMPARATOR

Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

Other: Optimized Usual Care (OUC)

Interventions

DESTRESS-TBEHAVIORAL

Usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider, and care coordination

Also known as: Delivery of Self-Training for Stressful Situations, Telephonic version
DESTRESS-T

Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

Optimized Usual Care (OUC)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\>18 years
  • DSM-IV diagnosis of PTSD (derived from the CAPS) due to combat in OIF/OEF deployment
  • Active duty personnel

You may not qualify if:

  • Active suicidal or violent ideation within the past two months as assessed by the MINI and a supplementary form developed by the project team (see Appendices)
  • Current participation in any active psychotherapy (e.g., psychoanalysis, CBT) for mood, anxiety or substance use disorders (as determined via service member self report and/or check of medical record)
  • Recurrent PTSD treatment failure in psychotherapy, as determined via consensus of study team members (Dr. Charles Engel, Dr. Brett Litz, and Dr. Kristie Gore)
  • Current alcohol dependence, as assessed by MINI
  • Acute psychosis, psychotic episode, or psychotic disorder diagnosis within the past year, as assessed by the MINI
  • Currently on an antipsychotic or mood-stabilizing agent for bipolar disorder or any disorder with psychotic features, as determined by medical record and/or self report
  • Unstable administration schedule or dosing of any antidepressant, anxiolytic, or sedative-hypnotic (i.e., will exclude for any related medication changes in the month prior to randomization), as determined by medical record or service member self report
  • Acute or unstable physical illness based on the judgment of the patient's primary care clinician and the study team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fort Benning - Martin Army Community Hospital

Columbus, Georgia, 31905, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • COL Charles C. Engel, MD, MPH

    Uniformed Services University of the Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Harper Cordova, MA

CONTACT

Kristie Gore, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dir., Deployment Health Clinical Center; Associate Professor, psychiatry, USUHS

Study Record Dates

First Submitted

December 12, 2011

First Posted

December 30, 2011

Study Start

January 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

January 12, 2012

Record last verified: 2012-01

Locations